18F-FET PET/CT in advanced head and neck squamous cell carcinoma: An intra-individual comparison with 18F-FDG PET/CT

Molecular Imaging and Biology

Volumn 13, Issue 5, 2011, Pages 1036-1042

  Haerle, Stephan Kurt ^a   Fischer, Dorothee R ^a   Schmid, Daniel T ^a   Ahmad, Nader ^a   Huber, Gerhard F ^a   Buck, Alfred ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

18F FDG PET CT; 18F FET PET CT; Head and neck cancer; Staging; Tracer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; O 2 FLUOROETHYL TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; COMPARATIVE STUDY; HEAD AND NECK TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;

EID: 84855677110     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0419-5     Document Type: Article

References (11)

1. Quon A, Fischbein NJ, McDougall IR et al (2007) clinical role of 18FFDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med 48(Suppl 1):58-67
2. Kao J, Vu HL, Genden EM et al (2009) The diagnostic and prognostic utility of positron emission tomography/computed tomography- based follow-up after radiotherapy for head and neck cancer. Cancer 115:4586-4594
3. De Boer JR, van der Laan BF, Pruim J et al (2002) Carbon-11 tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas. Eur J Nucl Med Imaging 29:1182-1187 (Pubitemid 34985363)
4. Kaim AH, Weber B, Kurrer MO et al (2002) (18)F-FDG and (18)F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 29:648-654 (Pubitemid 34439325)
5. Lindholm P, Leskinen S, Lapela M (1998) Carbon-11-methionine uptake in squamous cell head and neck cancer. J Nucl Med 39:1393-1397 (Pubitemid 28373564)
6. Pauleit D, Stoffels G, Schaden W et al (2005) PET with O-(2-18FFluoroethyl)- L-Tyrosine in peripheral tumors: First clinical results. J Nucl Med 46:411-416 (Pubitemid 43093148)
7. Pauleit D, Zimmermann A, Stoffels G et al (2006) 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer. J Nucl Med 47:256-261 (Pubitemid 46780890)
8. Balogova S, Périé S, Kerrou K et al (2008) Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma. Mol Imaging Biol 10:364-373
9. Rodrigues RS, Bozza FA, Christian PE et al (2009) Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med 50:1205-1213
10. Strobel K, Haerle SK, Stoeckli SJ et al (2009) Head and neck squamous cell carcinoma (HNSCC)- detection of synchronous primaries with (18) F-FDG-PET/CT. Eur J Nucl Med Mol Imaging 36:919-927
11. Brouwer J, Senft A, de Bree R et al (2006) Screening for distant metastases in patients with head and neck cancer: Is there a role for (18) FDG-PET? Oral Oncol 42:275-280 (Pubitemid 43246759)